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Granda – Ospedale Maggiore Policlinico, University of Milan, ItalySee Article, pages 913–920In the present issue, an elegant experiment extending the pro-
gramming hypothesis of pro-steatotic conditions in the offspring
of both the intra-uterine and the lactational phases is reported
[1].
Programming is deﬁned as the process by which early insults
at critical stages of development lead to permanent changes in
tissue structure and function [2]. Intra-uterine programming of
postnatal physiological functions has been demonstrated experi-
mentally in a number of species, including mammals. Environ-
mental insults can induce programming at different stages of
development, including peri-conceptual and pre-implantation
periods, up to early postnatal life. During the phases of rapid cell
growth, insults, which alter the supply, uptake, and utilization of
nutrients, may switch the cell behavior from proliferation to dif-
ferentiation with adverse consequences for total cell number, and
ultimately, organ size and function [2]. As the different fetal
organs grow at different rates during development, the timing
of the insult is important in determining the speciﬁcity of
programming.
In mammalian development, environmental information,
such as nutrient availability, is transferred from the mother to
embryo and fetus through the placenta, and to infant through lac-
tation. Therefore, programming is induced through the adaptive
responses that the fetus or infant makes to cues from the mother.
Fetal or perinatal responses may include changes in metabolism,
hormone production, and tissue sensitivity to hormones that in
turn, may affect the development of various organs, leading to
persistent alterations in metabolic homeostasis [3]. Maternal
hyperglycemia, for example, may lead to fetal hyperinsulinemia
and fat deposition, and evidence suggests that the offspring of
obese and/or diabetic women are at greater risk for developing
metabolic disorders, even during childhood [4]. Furthermore,
once the organism has been programmed, the responses to sub-
sequent environmental cues during infancy, childhood, andJournal of Hepatology 20
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The ability of an organism to adjust structure and function in
response to environmental cues has been named developmental
plasticity [5]. There is increasing evidence that epigenetic mech-
anisms underlie the processes of developmental plasticity, and,
ultimately, programming. Environmental cues, transduced by
the mother, may result in ﬁne regulation of gene expression
through speciﬁc changes in methylation, acetylation, and, micro-
RNA expression in fetal tissues [2]. In a rat model, maternal
undernutrition affects the expression of PPAR-a in the liver with-
out affecting the related transcription factor PPAR-c [6]. In a dif-
ferent rat model of intra-uterine growth retardation obtained by
the ligation of uterine arteries, the development of type 2 diabe-
tes has been associated with progressive epigenetic silencing of
Pdx1, a pancreatic and duodenal homeobox transcription factor
that regulates pancreas development and b-cell differentiation
[7]. In humans, the peri-conceptional exposure to famine during
the Dutch Hunger Winter in 1943–1945, has been associated
with persistent epigenetic changes in the IGF2 differentially
methylated region [8].
There is increasing evidence that maternal obesity is a risk
factor for obesity in the offspring. It has been reported that
24% of children of obese mothers were themselves obese at
age 4 years compared to 9% of children born from normal-
weight mothers [9]. Furthermore, a close relationship between
maternal weight gain during pregnancy and obesity in child-
hood has been reported [10]. More recently, it has been shown
that female mice, fed with high fat diet from before mating
through lactation, underwent weight gain and their offspring
developed hyperphagia, increased adiposity, reduced locomotor
activity, hypertension, and insulin resistance, thus suggesting
maternal diet induced developmental programming [11]. The
hypothalamus is emerging as a critical site for the integration
of nutritional, endocrine, and neural cues signaling the body’s
metabolic and nutritional status. These signals should normally
activate a negative feedback loop between the availability of
nutrients and their intake and metabolism [12]. These appetite
control circuits are plastic in early life and can be affected (‘‘pro-10 vol. 52 j 788–790
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grammed”) by nutritional factors. Maternal obesogenic diet is
able to alter metabolic function in neonatal offspring eliciting
the oversecretion of leptin which in turn leads to central leptin
resistance, permanently affecting hypothalamic function. In this
rat model both phosphorylation of STAT3 in the hypothalamic
arcuate nucleus, and the level of agouti-related peptide in the
hypothalamic paraventricular nucleus, are reduced [13]. In the
same rat strain, maternal uteroplacental insufﬁciency reduces
the expression of STAT3 and POMC in the hypothalamus of
the offspring [14]. Taken together, these data strongly suggest
an intra-uterine programming of the hypothalamic control of
appetite and energy homeostasis as a response to the nutrient
supply from mother to fetus.
Bruce et al. have also experimentally shown that maternal fat
intake contributes to the development of NASH in adult offspring,
through impaired hepatic mitochondrial metabolism and up-reg-
ulated hepatic lipogenesis [15]. These are potentially highly sig-
niﬁcant ﬁndings. The concept of maternal behavior affecting the
offspring in adulthood is consistent with the well established
association between in utero programming and long-term meta-
bolic consequences. Forsen et al. demonstrated that, in a multi-
variate analysis, maternal obesity in short women is strongly
associated with coronary heart disease in adult offspring [16].
The effect is more pronounced in the offspring of women with
a history of chronic malnutrition and who subsequently become
obese before conception. This ﬁnding, as recently reported by
Charlton in his Editorial [17], may explain the high prevalence
of metabolic syndrome among obese individuals in emerging
economies, such as India. A physiological basis for this observa-
tion was provided by Mitrani et al., who observed that metabolic
programming in the offspring of obese rats induces changes in
autonomic activity, including increased parasympathetic and
decreased sympathetic activity, in the postnatal maintenance of
hyperinsulinemia in response to the high caloric diet in utero.
The new information in the paper by Oben et al. demonstrates
that the lactational period may exert an imprinting metabolic
effect (or, alternatively, unmasking some gene-related functions)
on the later development of NALFD and other conditions (from
weight increase to biochemical markers) implicated in the devel-
opment of the metabolic syndrome [1]. Ozanne and Hales nicely
demonstrated in an animal model the strict interplay of maternal
nutritional conditions in utero and then in lactation on the life-
span of the offspring. These inﬂuences were clearly stronger than
post-weaning dietary habits [18].
Indeed, observations in humans are consistent with the
hypothesis that developmental plasticity extends further into
early postnatal life. Recently, Nobili et al. have suggested the pos-
sibility of an early imprinting effect of breastfeeding and/or
human milk that becomes more evident if the infant is later
exposed to unfavourable metabolic conditions such as obesity
and fatty liver [19]. A similar preventive effect of early breast-
feeding has been recently reported for lung compliance in 5- to
17-year-old children with cystic ﬁbrosis, where breastfeeding
longer than 4 months resulted in better lung function tests [20].
Some nutritional components of human milk may interact with
many regulatory systems, such as peroxisome proliferator acti-
vated receptors (PPAR, alpha and gamma) that are implicated in
the protection against ﬁbrosis. In particular, long-chain polyun-
saturated fatty acids of the n  3 series, especially docosahexae-
noic acid, delivered by human milk after prolonged lactation,
could act as PPAR-agonists either directly or indirectly [21].Journal of Hepatology 201PPAR-gamma expression is critical in reducing experimental liver
ﬁbrogenesis and a possible therapeutic role of its inhibition on
NAFLD has been proposed [22]. However, to what extent the
early effects of breastfeeding could translate into later protection
is a matter of speculation. Trophic factors present in human milk
could interact with hepatocytes within a neurohormonal milieu
that is quite different in breastfed as compared to formula-fed
infants. In the report by Oben et al., higher leptin levels were
identiﬁed in the milk of obese mothers, possibly contributing to
the negative programming effect.
At present, the programming hypothesis in humans is chal-
lenged against the possibility of indentifying key-events leading
to a deranged translation of the genetic inheritance, in order to
plan decisive preventive interventions – even to an individually
tailored basis. The question of the translation of the vicious circle
involving laboratory experiments, animal observations, human
epidemiology, and clinical trials is a burning one. Most criticisms
actually point out that we are still explaining mechanisms, but
the fundamental questions regarding treatment and prevention,
still rely on speculative standpoints. As a consequence, despite
the available experimental data, neonatologists are still focusing
their efforts on the stimulation of weight increase and catch-up
growth, without any distinction among the various populations
of preterm and growth-retarded infants.
Nevertheless, the recent addition of NALFD to the childhood-
onset metabolic syndrome is a key event, since the metabolic
mis-regulation of the liver may be counteracted by various
approaches, and the break-down of the vicious circle involving
liver steatosis and decreased insulin sensitivity could respond
to relatively simple interventions such as weight control, physical
exercise, and targeted use of docosahexaenoic acid [23].Acknowledgement
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